Sunesis Pharmaceuticals reported $-14799000 in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 4306M 135M
Actinium Pharmaceuticals ATNM:US $ -6469000 1.39M
Applied Genetic Technologies AGTC:US $ -16.42M 2.64M
AstraZeneca AZN:LN -1674000000 2.8B
Biogen BIIB:US $ 794M 308.3M
Cti Biopharma CTIC:US $ -23.38M 3.88M
Gilead Sciences GILD:US $ 3842M 1596M
Merk MRK:US $ 4826M 3212M
Mirati Therapeutics MRTX:US $ -79.5M 84.69M
Northwest Biotherapeutics NWBO:US -10049000 2.49M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Sunesis Pharmaceuticals SNSS:US $ -14.8M 5.74M
Tg Therapeutics TGTX:US $ -85.13M 7.64M
United Therapeutics UTHR:US $ 228.7M 8.8M
Vertex Pharmaceuticals VRTX:US $ 1054.51M 1092.47M